Link to this page
SNOMED CT, US Edition
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/SNOMEDCT/409731007
http://purl.bioontology.org/ontology/SNOMEDCT/409731007
|
|---|---|
| Preferred Name | International neuroblastoma pathology classification finding |
| Synonyms |
International neuroblastoma pathology classification finding (finding)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | International neuroblastoma pathology classification finding
|
|---|---|
| altLabel | International neuroblastoma pathology classification finding (finding)
|
| Type ID |
900000000000003001
900000000000013009
|
| Semantic type UMLS property | |
| interprets | |
| Effective time | 20040731
|
| cui | C1444031
|
| CTV3ID | XUbM2
|
| DEFINITION STATUS ID | 900000000000074008
|
| CASE SIGNIFICANCE ID | 900000000000448009
|
| tui | T033
|
| Active | 1
|
| Has associated morphology | |
| notation | 409731007
|
| type | |
| subClassOf | |
| Subset member | 6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT OF ANY AGE, WITH UNDIFFERENTIATED NEUROBLASTOMA (SCHWANNIAN STROMA-POOR) AND ANY MITOSIS-KARYORRHEXIS INDEX CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT LESS THAN 1.5 YEARS OLD, WITH POORLY DIFFERENTIATED OR DIFFERENTIATING NEUROBLASTOMA (SCHWANNIAN STROMA-POOR) AND HIGH MITOSIS-KARYORRHEXIS INDEX CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 409739009 | International neuroblastoma pathology classification: Unfavorable histology group, patient 1.5 yr up to but less than 5 yr, with poorly differentiated neuroblastoma and any MKI or differentiating neuroblastoma and intermediate or high MKI (finding) |
447562003~MAPRULE~TRUE
6011000124106~MAPRULE~IFA 409737006 | International neuroblastoma pathology classification: Unfavorable histology group, patient less than 1.5 years old, with poorly differentiated or differentiating neuroblastoma (Schwannian stroma-poor) and high mitosis-karyorrhexis index (finding) |
6011000124106~MAPRULE~IFA 409729003 | International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroma (Schwannian stroma-dominant) maturing, or mature (finding) |
6011000124106~MAPPRIORITY~7
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT 1.5 YR UP TO BUT LESS THAN 5 YR, WITH POORLY DIFFERENTIATED NEUROBLASTOMA AND ANY MKI OR DIFFERENTIATING NEUROBLASTOMA AND INTERMEDIATE OR HIGH MKI CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~4
6011000124106~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA
6011000124106~MAPTARGET~
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: FAVORABLE HISTOLOGY GROUP, PATIENT OF ANY AGE WITH GANGLIONEUROMA (SCHWANNIAN STROMA-DOMINANT) MATURING, OR MATURE CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPCATEGORYID~447638001
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: FAVORABLE HISTOLOGY GROUP, PATIENT OF ANY AGE WITH GANGLIONEUROBLASTOMA, INTERMIXED (SCHWANNIAN STROMA-RICH) CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: FAVORABLE HISTOLOGY GROUP, PATIENT AGE 1.5 YEARS UP TO BUT LESS THAN 5 YEARS, WITH DIFFERENTIATING NEUROBLASTOMA (SCHWANNIAN STROMA-POOR), AND LOW MITOSIS-KARYORRHEXIS INDEX CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPGROUP~1
6011000124106~MAPRULE~IFA 409738001 | International neuroblastoma pathology classification: Unfavorable histology group, patient 5 years or older, with any subtype of neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index |
6011000124106~MAPRULE~IFA 409733005 | International neuroblastoma pathology classification: Favorable histology group, patient less than 1.5 years of age, with poorly differentiated neuroblastoma (Schwannian stroma-poor), and low or intermediate mitosis-karyorrhexis index |
6011000124106~MAPPRIORITY~10
447562003~MAPADVICE~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA
6011000124106~MAPRULE~IFA 409733005 | International neuroblastoma pathology classification: Favorable histology group, patient less than 1.5 years of age, with poorly differentiated neuroblastoma (Schwannian stroma-poor), and low or intermediate mitosis-karyorrhexis index (finding) |
6011000124106~MAPPRIORITY~8
6011000124106~MAPRULE~IFA 409735003 | International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with ganglioneuroblastoma, nodular (composite Schwannian stroma-rich/stroma-dominant and stroma-poor) |
6011000124106~MAPRULE~IFA 409732000 | International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroblastoma, intermixed (Schwannian stroma-rich) (finding) |
447562003~MAPGROUP~1
6011000124106~MAPRULE~IFA 409732000 | International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroblastoma, intermixed (Schwannian stroma-rich) |
447562003~CORRELATIONID~447561005
900000000000509007~ACCEPTABILITYID~900000000000548007
6011000124106~MAPRULE~IFA 409736002 | International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with undifferentiated neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index (finding) |
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT OF ANY AGE, WITH GANGLIONEUROBLASTOMA, NODULAR CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPTARGET~C74.90
900000000000508004~ACCEPTABILITYID~900000000000548007
447562003~MAPTARGET~
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT OF ANY AGE, WITH GANGLIONEUROBLASTOMA, NODULAR (COMPOSITE SCHWANNIAN STROMA-RICH/STROMA-DOMINANT AND STROMA-POOR) CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
447562003~MAPPRIORITY~1
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: FAVORABLE HISTOLOGY GROUP, PATIENT LESS THAN 1.5 YEARS OF AGE, WITH POORLY DIFFERENTIATED NEUROBLASTOMA (SCHWANNIAN STROMA-POOR), AND LOW OR INTERMEDIATE MITOSIS-KARYORRHEXIS INDEX CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 409729003 | International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroma (Schwannian stroma-dominant) maturing, or mature |
6011000124106~MAPRULE~OTHERWISE TRUE
6011000124106~MAPPRIORITY~5
6011000124106~MAPPRIORITY~9
6011000124106~MAPCATEGORYID~447639009
6011000124106~MAPRULE~IFA 409737006 | International neuroblastoma pathology classification: Unfavorable histology group, patient less than 1.5 years old, with poorly differentiated or differentiating neuroblastoma (Schwannian stroma-poor) and high mitosis-karyorrhexis index |
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: FAVORABLE HISTOLOGY GROUP, PATIENT OF ANY AGE WITH GANGLIONEUROBLASTOMA, INTERMIXED CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 409736002 | International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with undifferentiated neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index |
6011000124106~MAPPRIORITY~1
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: FAVORABLE HISTOLOGY GROUP, PATIENT LESS THAN 1.5 YEARS OF AGE, WITH POORLY DIFFERENTIATED NEUROBLASTOMA CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 409734004 | International neuroblastoma pathology classification: Favorable histology group, patient age 1.5 years up to but less than 5 years, with differentiating neuroblastoma (Schwannian stroma-poor), and low mitosis-karyorrhexis index |
6011000124106~MAPPRIORITY~6
6011000124106~MAPRULE~IFA 409739009 | International neuroblastoma pathology classification: Unfavorable histology group, patient 1.5 yr up to but less than 5 yr, with poorly differentiated neuroblastoma and any MKI or differentiating neuroblastoma and intermediate or high MKI |
6011000124106~CORRELATIONID~447561005
6011000124106~MAPRULE~IFA 409735003 | International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with ganglioneuroblastoma, nodular (composite Schwannian stroma-rich/stroma-dominant and stroma-poor) (finding) |
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT LESS THAN 1.5 YEARS OLD, WITH POORLY DIFFERENTIATED OR DIFFERENTIATING NEUROBLASTOMA CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT 5 YEARS OR OLDER, WITH ANY SUBTYPE OF NEUROBLASTOMA (SCHWANNIAN STROMA-POOR) AND ANY MITOSIS-KARYORRHEXIS INDEX CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT OF ANY AGE, WITH UNDIFFERENTIATED NEUROBLASTOMA CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPRULE~IFA 409734004 | International neuroblastoma pathology classification: Favorable histology group, patient age 1.5 years up to but less than 5 years, with differentiating neuroblastoma (Schwannian stroma-poor), and low mitosis-karyorrhexis index (finding) |
900000000000497000~MAPTARGET~XUbM2
6011000124106~MAPRULE~IFA 409738001 | International neuroblastoma pathology classification: Unfavorable histology group, patient 5 years or older, with any subtype of neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index (finding) |
6011000124106~MAPRULE~TRUE
6011000124106~MAPPRIORITY~3
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: FAVORABLE HISTOLOGY GROUP, PATIENT OF ANY AGE WITH GANGLIONEUROMA CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: FAVORABLE HISTOLOGY GROUP, PATIENT AGE 1.5 YEARS UP TO BUT LESS THAN 5 YEARS, WITH DIFFERENTIATING NEUROBLASTOMA CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
6011000124106~MAPPRIORITY~2
6011000124106~MAPADVICE~IF INTERNATIONAL NEUROBLASTOMA PATHOLOGY CLASSIFICATION: UNFAVORABLE HISTOLOGY GROUP, PATIENT 5 YEARS OR OLDER, WITH ANY SUBTYPE OF NEUROBLASTOMA CHOOSE C74.90 | CONSIDER LATERALITY SPECIFICATION | MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT
447562003~MAPCATEGORYID~447638001
See more
See less
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |